FHL Management Team
-
Alex Yang, JD, LLM
Chief Executive Officer & Chair of the Board
-
Jay Vijayan, PhD
Chief Scientific Officer
-
Lisa Bollinger, MD
Chief Medical Officer
-
Eddy Zhu, PhD
Chief CMC Officer (Chemistry, Manufacturing, and Controls)
-
Andrew O
Chief Investment Officer
-
Minsu Kang, PhD
Director, Regulatory and Clinical Affairs
-
Valerie Yeung, CPA
Senior Finance Manager
FHL Scientific Advisory Board
-
Kalipada Pahan, PhD
Professor, Neurological Sciences, Biochemistry & Pharmacology at Rush University
-
Mitchel Berger, MD
Director of Brain Tumor Center at UCSF
-
Khalid Iqbal, PhD
Professor and Chairman of Neurochemistry at New York Institute for IBR
-
Han-Jun Kim, MD
Professor of Neurology at Seoul National University
FHL Board of Directors
-
Alex Yang, JD, LLM
Chief Executive Officer & Chair of the Board
-
Andrew O
Chief Investment Officer